NeuroNEXT supports clinical trials for neurological diseases by providing infrastructure and coordination through clinical trial sites and data centers. Proposals should focus on testing new therapies in adult and pediatric populations to improve trial efficiency and responsiveness to promising treatments.
Eligible applicants include academic institutions, small businesses, and industry collaborators involved in neuroscience clinical trials.
